tirzepatide methionine Microdosing Program Compounded Tirzepatide Weight Loss Program

Any licensed physician, nurse practitioner, or physician assistant can offer these services within their scope of practice

Vigorous shaking to speed up the process will cost you potency

Alberta occasionally approves coverage through special authorization, but approval rates sit below 15%

Will spending $1015k per patient-year save far more in future costs of diabetes, heart disease, etc

Lilly CEO David Ricks framed the approval in terms of access: " Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment, " Ricks said in the company's April 1 press release

Originally developed for type 2 diabetes, it has been FDA-approved for weight loss in overweight and obese individuals